Work

Supplementary Tables S1-S2 from An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Table 1. Clinical characteristics of 85 primary breast tumors used for statistical analysis; Supplementary Table 2. HER2 and HER2ï�„16 coexpression compared clinicopathological parameters.

DOI: 10.1158/1535-7163.22485182

Authors: Doyel Mitra, Michael J. Brumlik, Stella U. Okamgba, Yun Zhu, Tamika T. Duplessis, Jenny G. Parvani, Samuel M. Lesko, Edi Brogi, Frank E. Jones

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361891312

Cites:

Cited by:

Related to: 10